Advanced Search

 

Study ID Status Title Patient Level Data
A2260597 Terminated A study to assess the efficacy of paracetamol taken in combination with caffeine for the treatment of episodic tension type headache
A2260665 Completed A pivotal pharmacokinetic study investigating the extent of absorptions of paracetamol and caffeine for two different paracetomol formulations containing caffeine
A2750596 Completed A study investigating the pharmacokinetic profiles of four extended release paracetamol formulations
A2750605 Completed A single dose PK study investigating the extent of paracetamol absorption from two different sustained released paracetamol formulations
A2750606 Completed A single dose PK study investigating the extent of paracetamol absorption from two sustained release paracetamol formulations
A2750607 Completed A repeat dose PK study investigating the extent of paracetamol absorption from two sustained release paracetamol formulations
A2750894 Completed A Proof of Principal Study to Investigate the Pharmacokinetic Profiles of Sustained Release and Standard Paracetamol Formulations
A3360529 Completed A randomised, double-blind, evaluation of the effects of paracetamol on the BOLD fMRI response to painful stimuli in subjects with osteoarthritis
A3940666 Completed A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
A3950669 Completed A pharmacokinetic study investigating the rate and extent of paracetamol absorption of three experimental sustained release pediatric suspensions
A4000684 Completed A study to compare the analgesic efficacy of two different paracetamol doses as measured by post-operative dental pain relief
A4000685 Completed A study to compare the analgesic efficacy of two different paracetamol doses as measured by post-operative pain relief
A4010001 Completed A two centre, randomised, partially double-blind, double dummy, placebo-controlled, crossover study to investigate the effects of pre-treatment with a new chemical entity (NCE) and a single inhaled dose of fluticasone propionate (0.5 mg) on the allergen induced late asthmatic response in mild as ...
A4A10003 Completed A randomised, double-blind, placebo-controlled, 3-way cross-over study to investigate the effects of pre-treatment with single inhaled doses of an NCE and fluticasone propionate on the allergen induced late phase asthmatic response in mild asthmatic subjects. Study Listed on ClinicalStudyDataRequest.com
A4A10008 Completed An 8-day, randomised, placebo-controlled, three-way crossover trial of repeat doses of a new chemical entity (NCE), fluticasone propionate and placebo administered intranasally, blinded for fluticasone propionate versus placebo, in an environmental exposition unit, the Vienna Challenge Chamber (VCC) in subjects with seasonal allergic rhinitis (SAR) Study Listed on ClinicalStudyDataRequest.com
A4M105038 Completed Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Investigate the MRI Efficacy and the Safety of Six Months Administration of SB-683699 in Subjects with Relapsing-Remitting Multiple Sclerosis
A4M108119 Completed An open-label study of leukocyte counts in the cerebrospinal fluid and blood of subjects with relapsing forms of multiple sclerosis following treatment with firategrast
A4M109079 Completed An open-label, randomised, four period crossover study to investigate the relative pharmacokinetic profiles of tablets from three batches of firategrast with different surface areas and two different tablet formulations containing the same batch of firategrast, given as single 900mg doses to male and female subjects with a diagnosis of Multiple Sclerosis
A6480791 Completed A pharmacokinetic study investigating the rate and extent of absorption of paracetamol and an adjuvant from two different paracetamol formulations.
A6480804 Completed A single dose pharmacoscintigraphic study investigating the differences in gastrointestinal behaviour and paracetamol absorption between two paracetamol formulations
AA210005 Completed A randomised, double-blind, placebo-controlled, cross-over study to investigate the effects of pre-treatment with repeat inhaled doses of a new chemical entity on the allergen-induced late phase asthmatic response in mild asthmatic subjects. Study Listed on ClinicalStudyDataRequest.com
AA210010 Completed A randomised, double-blind, placebo-controlled, rising dose, 6-way crossover study to investigate the effect on heart rate of single doses of GW328267 (25 μg and 50 μg) and escalating cumulative doses of salbutamol (up to 1200 μg) administered alone and in combination to healthy male smokers. Study Listed on ClinicalStudyDataRequest.com
AA210012 Completed A randomised, double-blind, double dummy, placebo-controlled, three-way, balanced incomplete block, crossover study in patients with allergic rhinitis to compare the effect versus placebo of 7 days treatment with a new chemical entity (NCE) and 7 days treatment with intranasal fluticasone propionate 200 μg BID upon nasal clinical response after intranasal allergen challenge. Study Listed on ClinicalStudyDataRequest.com
AA210013 Completed A randomised, double-blind, placebo-controlled, crossover study to investigate the effects of pre-treatment with inhaled repeat doses of a new chemical entity (NCE) on the allergen induced late phase asthmatic response in mild asthmatic subjects. Study Listed on ClinicalStudyDataRequest.com
ABC107442 Completed A retrospective case-control study to estimate the sensitivity and specificity of a pharmacogenetic marker (HLA-B*5701) in subjects with and without hypersensitivity to abacavir.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.